Funding Opportunities: Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP)

NIGMS is pleased to announce our participation in Phase II of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP), a $500 million NIH-wide initiative to understand and reduce morbidity and mortality disparities for vulnerable and underserved populations disproportionately affected by COVID-19. The initiative funds a national coordination center and a network of projects across the United States aimed at improving COVID-19 testing and understanding COVID-19 health disparities. Four new RADx-UP Phase II funding opportunity announcements have been published: Community-Engaged COVID-19 Testing Interventions Among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) RFA-OD-21-008 Supports research projects that apply the scientific knowledge gained in 2020 and 2021 to expand testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and to address scientific questions on interventions to increase access and uptake of COVID-19 testing, given the increasing availability of SARS-CoV-2 vaccines. Application deadline: July 7, 2021 Earliest start date: October 2021 Notice of Special Interest: Emergency Competitive Revisions for Community-Engaged COVID-19 Testing Interventions Among Underserved and Vulnerable Populations (Emergency Supplement – Clinical Trial Optional) NOT-OD-21-103 Supports RADx-UP Phase I projects that apply the scientific knowledge gained in 2020 and 2021 to expand testin...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - Category: Biomedical Science Authors: Tags: Funding Opportunities COVID-19 Source Type: blogs